Literature DB >> 28472860

Peripheral nerve atrophy together with higher cerebrospinal fluid progranulin indicate axonal damage in amyotrophic lateral sclerosis.

Stefanie Schreiber1,2, Grazyna Debska-Vielhaber1, Susanne Abdulla1,2, Judith Machts1,2, Frank Schreiber1,2,3, Siegfried Kropf4, Peter KÖrtvelyessy1,2, Sonja KÖrner5, Katja Kollewe5, Susanne Petri5, Reinhard Dengler5, Wolfram S Kunz6, Peter J Nestor2, Stefan Vielhaber1,2.   

Abstract

INTRODUCTION: We aimed to investigate whether sonographic peripheral cross-sectional nerve area (CSA) and progranulin (PGRN), a neuritic growth factor, are related to each other and whether they interact to predict clinical and paraclinical measures in amyotrophic lateral sclerosis (ALS).
METHODS: We included 55 ALS patients who had forearm median and ulnar nerve CSA, cerebrospinal fluid (CSF) PGRN, and serum PGRN measures available. CSF PGRN was normalized against the CSF / serum albumin ratio (Qalb ). Using age, sex, height, and weight adjusted general linear models, we examined CSA × CSF PGRN interaction effects on various measures.
RESULTS: There was a medium-effect size inverse relationship between CSA and CSF PGRN, but not between CSA and serum PGRN. Lower CSA values together with higher CSF PGRN levels were linked to smaller motor amplitudes. DISCUSSION: In ALS, the constellation of peripheral nerve atrophy together with higher CSF PGRN levels indicates pronounced axonal damage. Muscle Nerve 57: 273-278, 2018.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  amyotrophic lateral sclerosis; biomarker; blood-brain barrier; motor amplitude; progranulin; ultrasound

Mesh:

Substances:

Year:  2017        PMID: 28472860     DOI: 10.1002/mus.25682

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

Review 1.  The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS.

Authors:  Elena Obrador; Rosario Salvador-Palmer; Rafael López-Blanch; Ali Jihad-Jebbar; Soraya L Vallés; José M Estrela
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

2.  Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis.

Authors:  Stephanie L Barnes; Neil G Simon
Journal:  Degener Neurol Neuromuscul Dis       Date:  2019-07-16

3.  One nerve suffices: A clinically guided nerve ultrasound protocol for the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis (ALS).

Authors:  Kai F Loewenbrück; Robin Werner; René Günther; Markus Dittrich; Robert Klingenberger; Heinz Reichmann; Alexander Storch; Andreas Hermann
Journal:  J Neurol       Date:  2020-12-23       Impact factor: 4.849

4.  Brevican and Neurocan Cleavage Products in the Cerebrospinal Fluid - Differential Occurrence in ALS, Epilepsy and Small Vessel Disease.

Authors:  Wilhelm Hußler; Lukas Höhn; Christopher Stolz; Stefan Vielhaber; Cornelia Garz; Friedhelm C Schmitt; Eckart D Gundelfinger; Stefanie Schreiber; Constanze I Seidenbecher
Journal:  Front Cell Neurosci       Date:  2022-04-11       Impact factor: 5.505

5.  CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline.

Authors:  Marc Suárez-Calvet; Anja Capell; Miguel Ángel Araque Caballero; Estrella Morenas-Rodríguez; Katrin Fellerer; Nicolai Franzmeier; Gernot Kleinberger; Erden Eren; Yuetiva Deming; Laura Piccio; Celeste M Karch; Carlos Cruchaga; Katrina Paumier; Randall J Bateman; Anne M Fagan; John C Morris; Johannes Levin; Adrian Danek; Mathias Jucker; Colin L Masters; Martin N Rossor; John M Ringman; Leslie M Shaw; John Q Trojanowski; Michael Weiner; Michael Ewers; Christian Haass
Journal:  EMBO Mol Med       Date:  2018-12       Impact factor: 12.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.